Clinical perspectives on vagus nerve stimulation: present and future

AdultPediatric
Written By Rodrigo Silva

Eibhlin Goggins, Shuhei Mitani, and Shinji Tanaka

Clinical Science (2022) 136 695–709
http://ow.ly/TauY50JmWEB

Hot Off The Press - This work by Goggins et al. (May 2022) reviewed the #preclinical and #clinical evidence for evaluating the treatment effect of vagus nerve stimulation (#VNS) in drug resistant epilepsy (#DRE).

The #mechanisms that VNS can reduce excitability in different brain regions, adjust the release of neurotransmitters and its anti-inflammatory effect on epilepsy were discussed in the article. Moreover, the treatment effects of VNS in other diseases, including depression, obesity, and headache, were discussed.

Rodrigo Silva
Previous

Up to What Extent Does Dravet Syndrome Benefit From Neurostimulation Techniques?
Next

Epilepsy surgery in the first six months of life: A systematic review and meta-analysis